GO
Loading...
 

Looking to JAZZ Up Your Portfolio?

Fri 07 Jun 13 | 06:25 PM ET
 Highlight transcript below to create clip
Transcript:  Print  |  Email
    This term does not appear
Go
 Click text to jump within video

Looking to JAZZ Up Your Portfolio?

Fri 07 Jun 13 | 06:25 PM ET
Jazz Pharmaceuticals' stock has roared, says Mad Money host Jim Cramer. The company gets 69 percent of its sales from its narcolepsy drug Xyrem which has a wall of patents protecting the drug from competition.
 
RELATED ARTICLES AND CONTENT
More Videos
Go
Displaying results for: Latest Video | US